First Author: M.Gavris ROMANIA
Co Author(s): G. Olaru D. Popa.
Purpose:
To present a new therapeutically option for surgical correction of moderate and high myopia in patients under the age of 40.
Setting:
Optisan Clinic, Cluj-Napoca, Romania
Methods:
Prospective clinical study performed on 10 patients (14 eyes) with mild and high myopia in which Acrysof Cachet Phakic IOLs were implanted. In the study were included 10 patients (14 eyes), 6 women and 4 men, with ages between 21 and 37 years. All patients had stable refraction and in all cases the target postoperative refraction was emmetropia. The preoperative measures included: visual acuity, postoperative refraction, phakic IOL position in vivo, endothelial cell density and adverse events.
Results:
The patients were evaluated at one day, one week, 6 weeks, 3 months, 6 months and 1 year postoperative. The uncorrected visual acuity was 20/40 or better in all eyes. 3 eyes (21.42%) had a visual acuity of 20/20, 7 eyes (50%) 20/30, and 4 eyes (28.58%) 20/40. The estimated postoperative refraction was obtained in 4 eyes (28.58%). The residual refractive error was within ±0.50 D of target in 10 eyes (71.42%). In all eyes the IOL Cachet position in vivo analyzed with Scheimpflug photography, was optimal at 2/3 from corneal endothelium and 1/3 from anterior surface of the lens. The endothelial cell loss varied between 1.98 and 2.2% at 3 months postoperative and was up to 2.82% at one year. In 2 patients (3 eyes 21.42%) we noticed an IOP raising at 26-28 mmHg at one week postoperative under topical treatment with steroids. In one eye (7.14%) we noticed stromal irian atrophy with secondary pupil change at 24 hours postoperative.
Conclusions:
The Acrysof phakic Cachet IOL is a good option for correction of mild and high myopia. The most important parameter in the selection of the phakic IOL dimension is the anterior chamber diameter (WTW). FINANCIAL DISCLOSURE?: No
Please wait while information is loading.
